Advancing Revolutionary Therapies
Cell and gene therapies have made impressive clinical progress but continue to face big hurdles. Nothing is standard about study design, study conduct or regulatory process in this specialized area.
Advancing Revolutionary Therapies
CMC Pitfalls: From Benchtop to IND
•
ART
•
Season 3
•
Episode 4
Listen as members of Veristat’s regulatory team outline the fundamentals— and the pitfalls— as you determine your readiness to file an Investigational New Drug (IND) from a manufacturing perspective.